47 Results

People

  1. Hudis
    Hudis
  2. Dickler
    Dickler
  3. Mao
    Mao
  4. Norton
    Norton
  5. Fornier
    Fornier
  6. Jhaveri
    Jhaveri
  7. Li
    Li
  8. Robson
    Robson
  9. Traina
    Traina
  10. Bao
    Bao

Groups

  1. Department of Medicine (38)
  2. Solid Tumor Oncology Division (32)
  3. Breast Medicine Service (30)
  4. Survivorship Research (26)
  5. Population Sciences Research Program (11)
  6. Division of Subspecialty Medicine (9)
  7. Epidemiology and Biostatistics (8)
  8. Integrative Medicine (7)
  9. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (6)
  10. Biostatistics Service (5)
  1. "aromatase inhibitors"
Formats
  1. Journal Article (45)
  2. Conference Paper (1)
  3. Review (1)
Groups
  1. Department of Medicine (38)
  2. Solid Tumor Oncology Division (32)
  3. Breast Medicine Service (30)
  4. Survivorship Research (26)
  5. Population Sciences Research Program (11)
  6. Division of Subspecialty Medicine (9)

More Groups

People
  1. Clifford Hudis (11)
  2. Maura Dickler (8)
  3. Jun Mao (6)
  4. Larry Norton (6)
  5. Komal Jhaveri (3)
  6. Mark Robson (3)

More People

Years
  1. 2025 (2)
  2. 2023 (2)
  3. 2022 (2)
  4. 2021 (2)
  5. 2019 (1)
  6. 2018 (2)

More Years

Publications
  1. Breast Cancer Research and Treatment (4)
  2. New England Journal of Medicine (4)
  3. Cancer (3)
  4. Clinical Breast Cancer (3)
  5. Journal of Clinical Oncology (3)
  6. Gynecologic Oncology (2)

More Publications

Publishers
  1. Elsevier Inc. (7)
  2. Springer (5)
  3. Massachusetts Medical Society (4)
  4. American Society of Clinical Oncology (3)
  5. Oxford University Press (3)
  6. Wiley Blackwell (3)

More Publishers

Results (47)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Adjuvant therapy for breast cancer: Practical lessons from the early breast cancer trialists' collaborative group
    Journal Article

    Hudis, C. A.; Dang, C. T.
    Breast Disease (2004)

    Fulltext@MSK | Save
  • Clinical trials update: Medical management of advanced breast cancer
    Journal Article

    Major, M. A.
    Cancer Nursing (2003)

    Fulltext@MSK | Save
  • A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer
    Journal Article

    Goss, P. E.; Ingle, J. N.; Martino, S.; Robert, N. J.; Muss, H. B.; Piccart, M. J.; Castiglione, M.; Tu, D.; Shepherd, L. E.; Pritchard, K. I.; more...
    New England Journal of Medicine (2003)

    Fulltext@MSK | Save
  • Current status and future potential role of exemestane in the treatment of early and advanced breast cancer (Review)
    Journal Article

    Crucitta, E.; Fornier, M. N.; Locopo, N.; Silvestris, N.; Lorusso, V.; De Lena, M.
    International Journal of Oncology (2002)

    Fulltext@MSK | Save
  • Aromatase inhibitors in breast cancer: An update
    Journal Article

    Lake, D. E.; Hudis, C.
    Cancer Control (2002)

    Fulltext@MSK | Save
  • The MORE trial: Multiple outcomes for raloxifene evaluation: Breast cancer as a secondary end point: Implications for prevention
    Conference Paper

    Dickler, M. N.; Norton, L.
    John Wiley & Sons (2001)

    Fulltext@MSK | Save
  • Randomized phase III trial comparing the new potent and selective third- generation aromatase inhibitor vorozole with megestrol acetate in postmenopausal advanced breast cancer patients
    Journal Article

    Goss, P. E.; Winer, E. P.; Tannock, I. F.; Schwartz, L. H.
    Journal of Clinical Oncology (1999)

    Fulltext@MSK | Save